Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludger M Dinkelborg

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolismNorman Koglin, Andre Mueller, Mathias Berndt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2013
Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancerRalf Lesche, Georg Kettschau, Alexey V Gromov, et al.
Nuclear Medicine and Biology|November 14, 2007
Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8Sabine Krause, Huub J Rennen, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragmentsDietmar Berndorff, Sandra Borkowski, Dieter Moosmayer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculatureBernard M Tijink, Dario Neri, C René Leemans, et al.
Journal of Medicinal Chemistry|February 24, 2007
Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studiesJohn E Cyr, Daniel A Pearson, David M Wilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteineSara Ahlgren, Helena Wållberg, Thuy A Tran, et al.
Journal of Medicinal Chemistry|September 3, 2013
Studies toward the development of new silicon-containing building blocks for the direct (18)F-labeling of peptidesLukas O Dialer, Svetlana V Selivanova, Carmen J Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsDieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2013
(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetryKamilla Smolarz, Bernd Joachim Krause, Frank-Philipp Graner, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolismNorman Koglin, Andre Mueller, Mathias Berndt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2013
Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancerRalf Lesche, Georg Kettschau, Alexey V Gromov, et al.
Nuclear Medicine and Biology|November 14, 2007
Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8Sabine Krause, Huub J Rennen, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragmentsDietmar Berndorff, Sandra Borkowski, Dieter Moosmayer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculatureBernard M Tijink, Dario Neri, C René Leemans, et al.
Journal of Medicinal Chemistry|February 24, 2007
Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studiesJohn E Cyr, Daniel A Pearson, David M Wilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteineSara Ahlgren, Helena Wållberg, Thuy A Tran, et al.
Journal of Medicinal Chemistry|September 3, 2013
Studies toward the development of new silicon-containing building blocks for the direct (18)F-labeling of peptidesLukas O Dialer, Svetlana V Selivanova, Carmen J Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsDieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2013
(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetryKamilla Smolarz, Bernd Joachim Krause, Frank-Philipp Graner, et al.
Pageof 4